Terms: = Endocrine gland cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
36 results:
1. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
[No Abstract] [Full Text] [Related]
2. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
[TBL] [Abstract] [Full Text] [Related]
3. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
[TBL] [Abstract] [Full Text] [Related]
4. Feasibility of a snowball sampling survey to study active surveillance for thyroid microcarcinoma treatment among endocrinologists and surgeons of Brazil.
Silva IMD; Nogueira TQDS; Couto DN; Lima PCTM; Bonfim NSC; Sousa IGV; Telles ACT; Hecht F; Alkmim NR; Penna GCE; Ferraz C; Tomimori E; Ramos HE
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S163-S169. PubMed ID: 35177356
[TBL] [Abstract] [Full Text] [Related]
5. Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies.
Searfoss R; Shah P; Ofori-Mensa K; Bussberg V; Tolstikov V; Greenwood B; Li H; Richardson K; Miller GM; DeCicco C; Granger E; Rodrigues LO; Grund EM; Moser AJ; Sarangarajan R; Narain NR; Kiebish MA
Sci Rep; 2022 Jan; 12(1):1186. PubMed ID: 35075163
[TBL] [Abstract] [Full Text] [Related]
6. Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer.
Ladekarl M; Rasmussen LS; Kirkegård J; Chen I; Pfeiffer P; Weber B; Skuladottir H; Østerlind K; Larsen JS; Mortensen FV; Engberg H; Møller H; Fristrup CW
Acta Oncol; 2022 Mar; 61(3):277-285. PubMed ID: 34879787
[TBL] [Abstract] [Full Text] [Related]
7. Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Trédan O; Provansal M; Abdeddaim C; Lardy-Cleaud A; Hardy-Bessard AC; Kalbacher E; Floquet A; Venat-Bouvet L; Lortholary A; Pop O; Frenel JS; Cancel M; Largillier R; Louvet C; You B; Zannetti A; Anota A; Treilleux I; Pissaloux D; Houlier A; Savoye AM; Mouret-Reynier MA; Meunier J; Levaché CB; Brocard F; Ray-Coquard I
Gynecol Oncol; 2022 Jan; 164(1):18-26. PubMed ID: 34696892
[TBL] [Abstract] [Full Text] [Related]
8. Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis.
Yagnik KJ; Erickson D; Bancos I; Atkinson JLD; Choby G; Peris-Celda M; Van Gompel JJ
Pituitary; 2021 Dec; 24(6):978-988. PubMed ID: 34580821
[TBL] [Abstract] [Full Text] [Related]
9. The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
Minakata M; Ito M; Kishi T; Hada M; Masaki Y; Nakamura T; Kousaka K; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2022 Feb; 69(2):165-172. PubMed ID: 34526424
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
[TBL] [Abstract] [Full Text] [Related]
11. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
Sugawara T; Ban D; Nishino J; Watanabe S; Maekawa A; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanaka S; Tanabe M
PLoS One; 2021; 16(4):e0249885. PubMed ID: 33844700
[TBL] [Abstract] [Full Text] [Related]
12. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
13. Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance.
Cheng SP; Lee JJ; Chien MN; Kuo CY; Jhuang JY; Liu CL
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1814-1819. PubMed ID: 32732093
[TBL] [Abstract] [Full Text] [Related]
14. What Can Social Media Tell Us About Patient Symptoms: A Text-Mining Approach to Online Ovarian cancer Forum.
Lee YJ; Park A; Roberge M; Donovan H
Cancer Nurs; 2022 Jan-Feb 01; 45(1):E27-E35. PubMed ID: 32649337
[TBL] [Abstract] [Full Text] [Related]
15. Current status and treatment modalities in metastases to the pituitary: a systematic review.
Ng S; Fomekong F; Delabar V; Jacquesson T; Enachescu C; Raverot G; Manet R; Jouanneau E
J Neurooncol; 2020 Jan; 146(2):219-227. PubMed ID: 31933258
[TBL] [Abstract] [Full Text] [Related]
16. treatment and outcomes of a Danish ovarian cancer population.
Berg T; Nøttrup TJ; Peen UBS; Roed H
Dan Med J; 2020 Jan; 67(1):. PubMed ID: 31908253
[TBL] [Abstract] [Full Text] [Related]
17. A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer.
Lu H; Arshad M; Thornton A; Avesani G; Cunnea P; Curry E; Kanavati F; Liang J; Nixon K; Williams ST; Hassan MA; Bowtell DDL; Gabra H; Fotopoulou C; Rockall A; Aboagye EO
Nat Commun; 2019 Feb; 10(1):764. PubMed ID: 30770825
[TBL] [Abstract] [Full Text] [Related]
18. Survival of Women With Type I and II Epithelial Ovarian cancer Detected by Ultrasound Screening.
van Nagell JR; Burgess BT; Miller RW; Baldwin L; DeSimone CP; Ueland FR; Huang B; Chen Q; Kryscio RJ; Pavlik EJ
Obstet Gynecol; 2018 Nov; 132(5):1091-1100. PubMed ID: 30303916
[TBL] [Abstract] [Full Text] [Related]
19. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.
Zhang L; Wang P; Qin Y; Cong Q; Shao C; Du Z; Ni X; Li P; Ding K
Oncogene; 2017 Mar; 36(9):1297-1308. PubMed ID: 27617577
[TBL] [Abstract] [Full Text] [Related]
20. Variations in cancer centers' use of cytology for the diagnosis of unresectable pancreatic cancer in the National cancer Data Base.
Gansler T; Fedewa SA; Lin CC; Jemal A; Ward EM
Cancer Cytopathol; 2016 Nov; 124(11):791-800. PubMed ID: 27348076
[TBL] [Abstract] [Full Text] [Related]
[Next]
